year 23, Issue 92 (11-2024)
J. Med. Plants 2024, 23(92): 1-22 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ebadollahi-Natanzi A, Arab-Rahmatipour G, Abedi M. Uric acid reducing plants with Xanthine Oxidase inhibitory effects: (A mini review article). J. Med. Plants 2024; 23 (92) :1-22
URL: http://jmp.ir/article-1-3681-en.html
URL: http://jmp.ir/article-1-3681-en.html
1- Department of Medicinal Plants, Imam Khomeini Higher Education Center, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran , ebad@ihec.ir
2- Department of Farabi Hospital Laboratory, Tehran University of Medical Sciences, Tehran, Iran
3- Agricultural Extension & Education Institute, Agricultural Research, Education and Extension Organization (AREEO), Tehran, Iran
2- Department of Farabi Hospital Laboratory, Tehran University of Medical Sciences, Tehran, Iran
3- Agricultural Extension & Education Institute, Agricultural Research, Education and Extension Organization (AREEO), Tehran, Iran
Abstract: (198 Views)
Background: Hyperuricemia is a common metabolic disorder of purines catabolism pathway that is associated with abnormal increases in uric acid levels. It is one of the important risk factors for gout and stress-oxidative related illness such as cancer and cardiovascular diseases. Objective: At present, allopurinol is used to treat it and the mechanism of this drug is to inhibit the enzyme xanthine oxidase (XO). In addition to side effects, this drug sometimes interacts with some other drugs. Therefore, the tendency of patients has increased to use medicinal plants for treatment of these diseases as the effectiveness of some plant compounds has been proven in various studies. Methods: In this study, uric acid reducing plants which had inhibitory properties on XO were reviewed. To get the comprehensive finding, keywords related to the subject of the study were searched in databases including: Scopus, PubMed, Google Scholar, Science Direct, Magiran and SID. Results: Our study showed, in order to inhibit XO enzyme and to be lowered uric acid levels by some plant families including Asteraceae, Malvaceae, Plantaginaceae, Fabaceae, Piperaceae, Moraceae, Asphodelaceae, Lamiaceae, Solanaceae, Anacardiaceae, Apiaceae, Amaryllidaceae, Tiliaceae, Oxalidaceae, Caricaceae, Sapotaceae, Arecaceae, Sapindaceae, Capparaceae, Lauraceae, Bignoniaceae, Polygonaceae, Calophyllaceae, Magnoliaceae, Portulacaceae and Menispermaceae, a specific dose of compounds of natural products in a range of 100 to 5000 mg/Kg is necessary. Conclusion: The presences of phenolic compounds, especially polyphenols and flavonoids such as chlorogenic acid and luteolin have been predominantly considered as the most important natural antioxidants inhibiting XO enzyme to treat hyperuricemia.
Type of Study: Review |
Subject:
Medicinal Plants
Received: 2024/06/7 | Accepted: 2025/01/7 | Published: 2024/11/30
Received: 2024/06/7 | Accepted: 2025/01/7 | Published: 2024/11/30
References
1. Gliozzi M, Malara N, Muscoli S and Mollace V. The treatment of hyperuricemia. Int. J. Cardiol. 2016; 213: 23-27. [DOI:10.1016/j.ijcard.2015.08.087]
2. Khalili M and Ebrahimzadeh MA. A review on antioxidants and some of their common evaluation methods. J. Mazandaran Univ. Med. Sci. 2015; 24(120): 188-208.
3. Kutzing MK and Firestein BL. Altered uric acid levels and disease states. J. Pharmacol. Exp. Ther. 2008; 324(1): 1-7. [DOI:10.1124/jpet.107.129031]
4. Crawley WT, Jungels CG, Stenmark KR and Fini MA. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia. Redox. Biol. 2022; 51: 102271. [DOI:10.1016/j.redox.2022.102271]
5. Xu L, Lu LL and Gao JD. Traditional Chinese herbal medicine plays a role in the liver, kidney, and intestine to Ameliorate Hyperuricemia according to experimental studies. Evid Based. Complement. Alternat. Med. 2021; 2021(1): 4618352. [DOI:10.1155/2021/4618352]
6. Levinson DJ and Becker MA. Clinical gout and the pathogenesis of hyperuricemia. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. 12th ed. Philadelphia: Lea & Febiger; 1993, pp: 1773-1806.
7. Strazzullo P and Puig JG. Uric acid and oxidative stress: Relative impact on cardiovascular risk. Nutr. Metab. Cardiovasc. Dis. 2007; 17(6): 409-414. [DOI:10.1016/j.numecd.2007.02.011]
8. Wang Y, Zhu JX, Kong LD, Yang C, Cheng CH and Zhang X. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice. Basic. Clin. Pharmacol. Toxicol. 2004; 94(5): 232-237. [DOI:10.1111/j.1742-7843.2004.pto940506.x]
9. Ebadollahinatanzi A and Arabrahmatipour G. The protective effects resulting from a combination of three medicinal plants on liver injury due to carbamazepine drug: A case report. Toxicol. Lett. 2016; 258S: 105-106. [DOI:10.1016/j.toxlet.2016.06.1443]
10. Lee Y-S, Son E, Kim S-H, Lee YM, Kim OS and Kim D-S. Synergistic uric acid-lowering effects of the combination of Chrysanthemum indicum Linne flower and Cinnamomum cassia (L.) J. Persl bark extracts. Evid-Based. Complement. Alternat. Med. 2017; 2017(1): 9764843. [DOI:10.1155/2017/9764843]
11. Arabrahmatipour G and Ebadollahinatanzi A. The accelerated removal of kidney stones by concomitant use of camel thorn distillate and Rowatinex drug: A case report. Toxicol. Lett. 2018; 295S: 265. [DOI:10.1016/j.toxlet.2018.06.1072]
12. Ebadollahinatanzi A and Arabrahmatipour G. P03-06 The effectiveness of herbal combination as complementary treatment process in a patient with COVID-19. Toxicol. Lett. 2022; 368S: 91-92. [DOI:10.1016/j.toxlet.2022.07.268]
13. Ebadollahi - Natanzi A. Toxicity comparison of four Cruciferous plant extracts and evaluation of their cytotoxicity - radical scavenging correlations. Jundishapur. J. Nat Pharm. Prod. 2018; 13(2): e13866. [DOI:10.5812/jjnpp.13866]
14. Lae KZW, Su SS, Win NN, Than NN and Ngwe H. Isolation of lasiodiplodin and evaluation of some biological activities of the stem barks of Phyllanthus albizzioides (Kurz) Hook.f. SciMedicine Journal 2019; 1(4): 199-216. [DOI:10.28991/SciMedJ-2019-0104-5]
15. Ebadollahi-Natanzi A and Arab-Rahmatipour G. Psyllium together with Allopurinol can efficiently reduce the increased serum level of uric acid, creatinine and urea: A case report report. Iranian Journal of Toxicology 2017; 11(4): 51-56. [DOI:10.29252/arakmu.11.4.51]
16. Sattarzade Badkoobeh R, Nozari Y, Larti F, safari S, Ahmadi F and Emami M. Allopurinol effects on diastolic dysfunction in ESRD patients with hyperuricemia. Tehran Univ. Med. J. 2011; 68(10): 618-623.
17. Haidari F, Rashidi M, Keshavarz S, Mahboob SA, Eshraghian MR and Shahi MM. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak. J. Biol. Sci. 2008; 11(14): 1779-1784. [DOI:10.3923/pjbs.2008.1779.1784]
18. Maia L, Duarte RO, Ponces-Freire A, Moura JJG and Mira L. NADH oxidase activity of rat and human liver xanthine oxidoreductase: potential role in superoxide production. J. Biol. Inorg. Chem. 2007; 12(6): 777-787. [DOI:10.1007/s00775-007-0229-7]
19. Hamidpour M, Saiidi K, Taslimi R, Khadem Maboudi A and Gharehbaghian A. Detection of the effect of anti-oxidant drugs on platelet xanthine oxidase and lipid peroxidase in the patients with myocardials infraction. Sci. J. Iran. Blood Transfus. Organ. 2012; 9(3): 300-307.
20. Tsai C-W, Lin S-Y, Kuo C-C and Huang C-C. Serum uric acid and progression of kidney disease: A longitudinal analysis and mini- review. PLoS One 2017; 12(1): e0170393. [DOI:10.1371/journal.pone.0170393]
21. Momeni A, Mir Hoseini M and Niazi E. Correlation of serum uric acid and proteinuria in patients with type 2 diabetes mellitus. Journal of Isfahan Medical School 2011; 28(118): 1232-1239.
22. Rashid I, Katravath P, Tiwari P, D'Cruz S, Jaswal S and Sahu G. Hyperuricemia-a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis. Exploration of Medicine. 2022; 3(3): 249-259. [DOI:10.37349/emed.2022.00089]
23. Rao TMV and Vanukuri NK. A study on serum uric acid levels in type 2 diabetes mellitus and its association with cardiovascular risk factors. IAIM. 2016; 3(12): 148-155.
24. Alemayehu E, Fiseha T, Bambo GM, Sahile Kebede S, Bisetegn H, Tilahun M, Debash H, Ebrahim H, Mohammed O, Belete MA and Gedefie A. Prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa: a systematic review and meta-analysis. BMC Endocr. Disord. 2023; 23(1): 153. [DOI:10.1186/s12902-023-01408-0]
25. Ghasemi Basir HR and Mosavi Bahar SH. A survey of epidemiologic factors in patients with urinary stones in Hamadan. Avicenna. J. Clin. Med. 2016; 23(2): 157-163.
26. Oral A, Sahin T, Turker F and Kocak E. Relationship between serum uric acid levels and nonalcoholic fatty liver disease in non-obese patients. Medicina. 2019; 55(9): 600. [DOI:10.3390/medicina55090600]
27. Zheng X, Gong L, Luo R, Chen H, Peng B, Ren W and Wang Y. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids in Health and Disease 2017; 16(1): 202. [DOI:10.1186/s12944-017-0531-5]
28. Liu L, Yu C, Yang F, Yuan Z, Wang Q, Liu S, Zuo C and Guan Q. Maternal hyperuricemia superimposed on maternal hypertension aggravates the risk of small-for-gestational-age fetus. Life Sci. 2019; 228: 215-20. [DOI:10.1016/j.lfs.2019.04.033]
29. Tan J, Fei H, Chen L and Zhu X. The association of hyperuricemia and maternal and fetal outcomes among pregnant women: a meta-analysis. J. Matern. Fetal. Neonatal. Med. 2023; 36(1): 2212830. [DOI:10.1080/14767058.2023.2212830]
30. Roddy E and Choi HK. Epidemiology of gout. Rheum. Dis. Clin. North. Am. 2014; 40(2): 155-175. [DOI:10.1016/j.rdc.2014.01.001]
31. Martinon F, Pétrilli V, Mayor A, Tardivel A and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440(7081): 237-241. [DOI:10.1038/nature04516]
32. Abd El-Rahman HSM and Abd-ELHak NAM. Xanthine oxidase inhibitory activity and antigout of Celery Leek Parsley and Molokhia. Advances in Biochemistry 2015; 3(4): 40-50. [DOI:10.11648/j.ab.20150304.11]
33. Singh H, Krishna G and Baske P. Plants used in the treatment of joint diseases (rheumatism, arthritis, gout and lumbago) in Mayurbhanj district of Odisha, India. Rep. Opin. 2010; 2(9): 22-26.
34. Perez-Ruiz F, Dalbeth N and Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv. Ther. 2015; 32(1): 31-41. [DOI:10.1007/s12325-014-0175-z]
35. Sweeney AP, Wyllie SG, Shalliker RA and Markham JL. Xanthine oxidase inhibitory activity of selected Australian native plants. J. Ethnopharmacol. 2001; 75(2-3): 273-277. [DOI:10.1016/S0378-8741(01)00176-3]
36. Kostić DA, Dimitrijević DS, Stojanović GS, Palić IR, Đorđević AS and Ickovski JD. Xanthine oxidase: isolation, assays of activity, and inhibition. J. Chem. 2015; 2015(1): 294858. [DOI:10.1155/2015/294858]
37. Alqahtani MJ and Alshamrani AM. Overview of allopurinol decisions in primary care: A narrative review. The Egyptian Journal of Hospital Medicine 2018; 72(2): 3909-3913. [DOI:10.21608/ejhm.2018.9068]
38. Nguyen TD, Thuong PT, Hwang IH, Hoang TKH, Nguyen MK, Nguyen HA and Na M. Anti-hyperuricemic, anti-inflammatory and analgesic effects of Siegesbeckia orientalis L. resulting from the fraction with high phenolic content. BMC Complement. Altern. Med. 2017; 17(1): 191. [DOI:10.1186/s12906-017-1698-z]
39. Ebadollahi-Natanzi A, Rahimi H, Arab-Rahmatipour M and Arab-Rahmatipour G. Study on the essential laboratory educations for herbalists and its necessity in providing health for recipients of herbal remedies. Horizon of Medical Education Development 2020; 10(2): 38-48.
40. Ebadollahinatanzi A, Arabrahmatipour G and Abedi M. COVID-19, health recovery by medicinal plants (health solutions): An overview. Toxicol. Lett. 2021; 350: S136. [DOI:10.1016/S0378-4274(21)00564-6]
41. Li Z, Tang T, Liang S, Ning X, Bai M and Wu H. The synthesis and storage sites of phenolic compounds in the root and rhizome of Echinacea purpurea. Am. J. Plant. Sci. 2012; 3(4): 551-558. [DOI:10.4236/ajps.2012.34066]
42. Kong LD, Yang C, Ge F, Wang HD and Guo YS. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J. Ethnopharmacol. 2004; 93(2-3): 325-330. [DOI:10.1016/j.jep.2004.04.008]
43. Ebadollahinatanzi A and Arabrahmatipour G. The possibility use of psyllium as appropriate alternative for allopurinol in treatment of hyperuricemic patient: A case report. Toxicol. Lett. 2018; 295S: 93. [DOI:10.1016/j.toxlet.2018.06.584]
44. Hirano M, Takeda S, Hitoe S and Shimoda H. Luteolin-rich chrysanthemum flower extract suppresses baseline serum uric acid in Japanese subjects with mild hyperuricemia. Integr. Mol. Med. 2017; 4(2): 1-5. [DOI:10.15761/IMM.1000275]
45. Zargari A. Medicinal plants. 8th ed. Tehran: University of Tehran Press (UTP); 2014.
46. Marpaung B and Siregar J. Effects of Sidaguri (Sida rhombifolia L.) on uric acid and C-reactive protein (CRP) in patients with gouty arthritis. GJRA. 2018; 7(9): 59-61.
47. Mozaffarian V. Identification of medicinal and aromatic plants of Iran. 2nd ed. Tehran: Farhang Moaser Publishers; 2015. 1350 pp.
48. Nile SH and Khobragade C. Phytochemical analysis, antioxidant and xanthine oxidase inhibitory activity of Tephrosia purpurea Linn. root extract. Indian J. Nat. Prod. Resour. 2011; 2(1): 52-58.
49. Faizal F, Nauphar D, Pratamawati TM and Brajawikalpa RS. Effectiveness of betel leaves (Piper betle L.) and breadfruit leaves (Artocarpus atilis) in reducing uric acid levels in hyperuricemic male white rats (Rattus norvegicus). Journal of Physics: Conference Series. 2019; 1146: 012007. [DOI:10.1088/1742-6596/1146/1/012007]
50. Tanomand S, Hosseini E and Edalatmanesh MA. Effect of alcoholic extract of Aloe vera Gel (Aloe barabadensis) on serum urea, uric acid and creatinine levels and tissue structure of kidney in adult mature mice treated with Ethidium Bromide. J. Birjand Univ. Med. Sci. 2018; 25(3): 193-202.
51. Spanou C, Veskoukis AS, Kerasioti T, Kontou M, Angelis A, Aligiannis N, Skaltsounis AL and Kouretas D. Flavonoid glycosides isolated from unique legume plant extracts as novel inhibitors of xanthine oxidase. PloS ONE 2012; 7(3): e32214. [DOI:10.1371/journal.pone.0032214]
52. Saghafi E, Mianabadi M and Hadadchi G. Inhibition effects of Teucrium polium extract on gout. Zahedan J. Res. Med. Sci. 2013; 15(11): e92791.
53. Hoshani M, Mianabadi M, Aghdasi M and Azim-Mohseni M. Inhibitory effect of Physalis alkekengi extracts in different phenological stages on xanthine oxidase activity. Physiol. Pharmacol. 2012; 16(3): 300-309.
54. Das A, Modak P, Sarkar AP, Halder S, Sarkar BK, Chowdhury AR, et al. Promising actions of certain medicinal and dietary plants for the management of hyperuricemia as a natural remedy: A review. Asian J. Pharmacy and Pharmacol. 2020; 6(4): 284-297. [DOI:10.31024/ajpp.2020.6.4.5]
55. Trabsa H, Baghiani A, Boussoualim N, Krache I, Khennouf S, Charef N and Arrar L. Kinetics of inhibition of xanthine oxidase by Lycium arabicum and its protective effect against oxonate- induced hyperuricemia and renal dysfunction in mice. Trop. J. Pharm. Res. 2015; 14(2): 249-256. [DOI:10.4314/tjpr.v14i2.9]
56. Azmi SMN, Jamal P and Amid A. Xanthine oxidase inhibitory activity from potential Malaysian medicinal plant as remedies for gout. Int. Food. Res. J. 2012; 19(1): 159-165.
57. Kuo C-Y, Kao E-S, Chan K-C, Lee H-J, Huang T-F and Wang C-J. Hibiscus sabdariffa L. extracts reduce serum uric acid levels in oxonate-induced rats. J. Funct. Foods. 2012; 4(1): 375-381. [DOI:10.1016/j.jff.2012.01.007]
58. Roohbakhsh A and Karimi G. In vitro evaluation of xanthine oxidase inhibitory activity of aqueous extracts of six medicinal plants. J. Med. Plants. 2009; 8(30): 84-91.
59. Ferraz-Filha ZS, Ferrari FC, Araújo MCdPM, Bernardes ACFPF and Saúde-Guimarães DA. Effects of the aqueous extract from Tabebuia roseoalba and phenolic acids on hyperuricemia and inflammation. Evid Based. Complement. Altern. Med. 2017; 2017: 2712108. [DOI:10.1155/2017/2712108]
60. Apaya KL and Chichioco-Hernandez CL. Xanthine oxidase inhibition of selected Philippine medicinal plants. J. Med. Plants Res. 2011; 5(2): 289-292. doi: 10.5897/ JMPR.9001299.
61. Eidi A. Antidiabetic effect of ethanolic extract of Salvia syriaca aerial parts in normal and streptozotocin-induced diabetic rats. Journal of Comparative Pathobiology 2014; 11(46): 1363-1372.
62. Lemos Lima Rde C, Ferrari FC, de Souza MR, de Sa Pereira BM, de Paula CA and Saude-Guimaraes DA. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis. J. Ethnopharmacol. 2015; 161: 194-199. [DOI:10.1016/j.jep.2014.11.051]
63. Ebadollahi-Natanzi A and Arabrahmatipour G. Uric acid lowering effects of Psyllium seeds on a hyperuricemic patient: A case report and review of literature. Asia. Pac. J. Med. Toxicol. 2020; 9(1): 21-24.
64. Pourmorad F, Hosseinimehr SJ and Shahabimajd N. Antioxidant activity phenol and flavonoid contents of some selected Iranian medicinal plants. Afr. J. Biotechnol. 2006; 5(11): 1142-1145.
65. Chen L, Luo Z, Wang M, Cheng J, Li F, Lu H, He Q,You Y, Zhou X, Kwan HY, Zhao X and Zhou L. The efficacy and mechanism of Chinese herbal medicines in lowering serum uric acid l: a systematic review. Fronti. pharmacol. 2021; 11: 578318. [DOI:10.3389/fphar.2020.578318]
66. Dong L, Zhang S, Chen L, Lu J, Zhao F, Long T,Wen J, Huang J, MaoY, Huang J, Qi Z, Zhang J, Li L and Dong Y. In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from Amomumvillosum Lour. Biomed. Pharmacother. 2023; 161: 114532. [DOI:10.1016/j.biopha.2023.114532]
67. Cheng-Yuan W and Jian-Gang D. Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components. Front. Nutr. 2023; 10: 1186161. [DOI:10.3389/fnut.2023.1186161]
68. Ebadollahi-Natanz A and Arab-Rahmatipour G. An overview on toxicity, adverse effects and therapeutic properties of some medicinal plants. Razi Journal of Medical Sciences 2023; 30(156): 1-20. [DOI:10.47176/rjms.30.156]
69. Baharvand B, Namdari M, Sherkhani Y and Nazari A. Inspection of Digoxin level in cardiac heart failure patients. Yafte 2006; 7(1): 43-49.
70. Ramezannezhad R, Aghdasi M and Fatemi M. An investigation on cichoric acid, chlorogenic, caffeic acid content and antioxidant activity in some Iranian native species compared to Echinacea purpurea L. in different developmental stages. IJMAPR. 2019; 34(6): 909-923.
71. Lago J, oledo-Arruda T, Mernak M, Barrosa K, Martns M, Tiberio L and Prado CM. Structure-activity association of flavonoids in lung diseases. Molecules (Basel, Switzerland) 2014; 19(3): 3570-3595. [DOI:10.3390/molecules19033570]
72. Mo SF, Zhou F, Lv YZ, Hu QH, Zhang DM and Kong LD. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol. Pharm. Bull. 2007; 30(8): 1551-1556. [DOI:10.1248/bpb.30.1551]
73. Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006; 160(1): 1-40. [DOI:10.1016/j.cbi.2005.12.009]
74. Trejo-Téllez LI, Estrada-Ortiz E, Gómez-Merino FC, Becker C, Krumbein A and Schwarz D. Flavonoid, nitrate and glucosinolate concentrations in Brassica species are differentially affected by photosynthetically active radiation, phosphate and phosphite. Frontiers in Plant Science 2019; 10(371): 1-16. [DOI:10.3389/fpls.2019.00371]
75. Khosravi A and Omid Ali F. The effect of Saffron stigmas aqueous extracts on serum cardiac troponin T and creatine kinase MB isoenzyme of male rats following an exhaustive exercise. J. Arak Uni. Med. Sci. 2018; 21(2): 43-54.
76. Reis JF, Monteiro VVS, de Souza Gomes R, do Carmo MM, da Costa GV, Ribera PC and Monteiro MC. Action mechanism and cardiovascular effect of anthocyanins: a ystematic review of animal and human studies. J. Transl. Med. 2016; 14(315): 1-16. [DOI:10.1186/s12967-016-1076-5]
77. Hofmann E, Webster J, Kidd T, Kline R, Jayasinghe M and Paula S. Coumarins with xanthine oxidase inhibiting and radical scavenging properties: Tools to combat oxidative stress in cells. IJBBB. 2014; 4(4): 234-239. [DOI:10.7763/IJBBB.2014.V4.346]
78. Qian D, Zhao Y, Yang G and Huang L. Systematic review of chemical constituents in the genus Lycium (Solanaceae). Molecules (Basel, Switzerland) 2017; 22(6): 911. [DOI:10.3390/molecules22060911]
79. Ahmadi Golsefidi M, Eshaghi Z and Tazikeh Lemeski E. Extraction and determination of chlorogenic acid in Echinacea purpurea using a novel solid phase micro extraction method. Eco-phytochemical. J. Med. Plants. 2013; 1(2): 1-13.
80. Meng Z-Q, Tang Z-H, Yan Y-X, Guo C-R, Cao L, Ding G, Huang W-Z, Wang Z-Z, D G Wang K, Xiao W, Yang Z-L. Study on the anti-gout activity of chlorogenic acid:improvement on hyperuricemia and gouty inflammation. Am. J. Chinese. Med. 2014; 42(06): 1471-1483. [DOI:10.1142/S0192415X1450092X]
81. Mulabagal V, Wang H, Ngouajio M and Nair MG. Characterization and quantification of health beneficial anthocyanins in leaf chicory (Cichorium intybus) varieties. Eur. Food. Res. Technol. 2009; 230(1): 47-53. [DOI:10.1007/s00217-009-1144-7]
82. Afify H, Abo-Youssef AM, Abdel-Rahman HM, Allam S and Azouz AA. The modulatory effects of cinnamaldehyde on uric acid level and IL-6/JAK1/STAT3 signaling as a promising therapeutic strategy against benign prostatic hyperplasia. Toxicol. Appl. Pharmacol. 2020; 402: 115122. [DOI:10.1016/j.taap.2020.115122]
83. Kostova I, Bhatia S, Grigorov P, Balkansky S, Parmar VS, Prasad AK and Saso L. Coumarins as antioxidants. Curr. Med. Chem. 2011; 18(25): 3929-3951. [DOI:10.2174/092986711803414395]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
